Literature DB >> 15384885

Selective neonatal BCG vaccination.

D Bakshi1, N Sharief.   

Abstract

AIMS: To assess the implementation of the "Selective Neonatal BCG Immunisation Policy", and to study the causes of non-compliance, or failure of uptake of BCG immunization.
METHODS: The Birth Register data were used to generate a list of babies born in the catchment area of Basildon and Thurrock NHS Trust between 1 January 2001 and 31 December 2001 who were eligible for BCG immunization. The Community Child Health computer was used to generate information about their BCG immunization status.
RESULTS: 201 children were included in the study. One hundred and seventy-one children had received BCG immunization in the neonatal period, out of which 169 had received it before discharge from the hospital. Two children were immunized in the community in the neonatal period. Thus, 85% of the newborns eligible for BCG immunization received their vaccination in the neonatal period.
CONCLUSIONS: The current "Neonatal BCG Immunisation Policy" is effective, and there is a high uptake of the vaccine in the neonatal period within the hospital itself. Newborn infants who do not receive BCG immunization in hospital rarely get immunized in the community.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15384885     DOI: 10.1080/08035250410033097

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

Review 1.  Interventions delivered in secondary or tertiary medical care settings to improve routine vaccination uptake in children and young people: a scoping review.

Authors:  Sarah Blagden; Kathryn Newell; Nareh Ghazarians; Sabrena Sulaiman; Lucy Tunn; Michael Odumala; Rachel Isba; Rhiannon Edge
Journal:  BMJ Open       Date:  2022-08-02       Impact factor: 3.006

2.  BCG vaccination in England since 2005: a survey of policy and practice.

Authors:  Daniel Pilger; Patrick Nguipdop-Djomo; Ibrahim Abubakar; David Elliman; Laura C Rodrigues; John M Watson; Vera Eastman; Punam Mangtani
Journal:  BMJ Open       Date:  2012-09-10       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.